Toxic nodule: wait or treat?
Saba Hafeez, Paul Carroll, Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), Anand Velusamy(Guy's and St Thomas' NHS Foundation Trust), R.H. Naveen Kumar
Cited by 0
Related Papers
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
|Diabetes|2014|244
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
|Science Translational Medicine|2017|215
Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death
|Diabetes|2011|213
Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis
|Diabetic Medicine|2000|177
Detection of growth hormone abuse in sport
|Growth Hormone & IGF Research|2007|144